Summary
Lupus anticoagulant associated with thrombocytopenia, thrombosis or recurrent abortions was diagnosed in 2 epileptic patients chronically treated with anticonvulsant drugs. The immunoglobulin fractions containing the anticoagulant activity were isolated and characterized. A search for lupus inhibitor was carried out in 96 consecutively examined patients, but no further cases were found. Although rarely, lupus anticoagulant and epilepsy may be associated. Whether lupus anticoagulant is causally related with epileptic seizures or secondary to the use of antiepileptic drugs remains to be established.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boxer M., Ellman L., Carvalho A.: The lupus anticoagulant — Arthr. and Rheum.19, 1244, 1976.
Canoso R. T., Sise M. S.: Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities — Amer. J. Haematol.12, 121, 1982.
Editorial: Lupus anticoagulant — Lanceti, 1157, 1984.
Elias M., Eldor A.: Thromboembolism in patients with the ‘lupus’-type circulating anticoagulant — Arch. intern. Med.144, 510, 1984.
Exner T., Rickard A., Kronenberg H.: A sensitive test demonstrating lupus anticoagulant and its behavioural patterns — Brit. J. Haematol.40, 143, 1978.
Feinstein D. I., Rapaport S. I.: Acquired inhibitors of blood coagulation — Progr. Haemost. Thrombos.1, 75, 1972.
Finazzi G., Cortelazzo S., Viero P., Barbui T.: IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters — J. Amer. med. Ass.255, 39, 1986.
Hughes G. R. V.: Thrombosis, abortion, cerebral disease and the lupus anticoagulant — Brit. med. J.287, 1088, 1983.
Landi G., Calloni M. V., Sabbadini M. G., Mannucci P. M., Candelise L.: Recurrent ischaemic attacks in two young adults with lupus anticoagulant — Stroke14, 377, 1983.
Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C.: Fetal survival after prednisone suppression of maternal lupus anticoagulant — Lanceti, 1361, 1983.
Mannucci P. M., Canciani M. T., Mari D., Meucci P.: The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant — Scand. J. Haematol.22, 423, 1979.
Rall T. W., Schleifer L. S.: Drugs effective in the therapy of the epilepsies. In:Goodman L. S., Gilman A. (Eds): The pharmacological basis of therapeutics. 6th ed., MacMillan, New York, 1980; chapt. 20, p. 448.
Reece E. A., Clyne L. P., Romero R., Hobbins J. C.: Spontaneous factor XI inhibitors — Arch. intern. Med.144, 525, 1984.
Schleider M. A., Nachman R. L., Jaffe E. A., Coleman M.: A clinical study of the lupus anticoagulant — Blood48, 499, 1976.
Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J.: The 1982 revised criteria for the classification of systemic lupus erythematosus — Arthr. and Rheum.25, 1271, 1982.
Williams H., Laurent R., Gibson T.: The lupus coagulation inhibitor and venous thrombosis: a report of four cases — Clin. Lab. Haematol.2, 139, 1980.
Yagnik P., Dhopesh V.: Stroke and circulating lupus — Stroke15, 388, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finazzi, G., Galli, M., Viero, P. et al. Association between lupus anticoagulant and epilepsy. La Ricerca Clin. Lab. 17, 35–39 (1987). https://doi.org/10.1007/BF02909386
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02909386